Results 241 to 250 of about 697,969 (251)
Some of the next articles are maybe not open access.
Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients.
Current Alzheimer Research, 2016BACKGROUND/OBJECTIVES Increasing evidence suggests the importance of neuroinflammation in the pathogenesis of Alzheimer's disease (AD), which is a complex neurodegenerative disorder. Complement activation occurs in the brain of patients with AD and seems
M. Zorzetto +7 more
semanticscholar +1 more source
The Journal of Immunology, 1996
Abstract A key step in the elimination of invading pathogens from the body is the covalent binding of complement proteins C3b and C4b to their surface. However, many pathogens have evolved mechanisms to avoid the complement system of the host. Understanding how these mechanisms work may lead to more efficacious forms of therapy.
P, Accardo +4 more
openaire +2 more sources
Abstract A key step in the elimination of invading pathogens from the body is the covalent binding of complement proteins C3b and C4b to their surface. However, many pathogens have evolved mechanisms to avoid the complement system of the host. Understanding how these mechanisms work may lead to more efficacious forms of therapy.
P, Accardo +4 more
openaire +2 more sources
European Journal of Immunology, 1984
AbstractA human monoclonal IgE from patient DES, IgE (DES), has been shown to activate the classical pathway of complement. The mechanism of this activation has been investigated and can be summarized as follows: (a) IgE (DES) is able to bind and activate C1 in a dose‐dependent fashion.
openaire +3 more sources
AbstractA human monoclonal IgE from patient DES, IgE (DES), has been shown to activate the classical pathway of complement. The mechanism of this activation has been investigated and can be summarized as follows: (a) IgE (DES) is able to bind and activate C1 in a dose‐dependent fashion.
openaire +3 more sources
Biochemistry, 2002
C4b-binding protein (C4BP), an important inhibitor of complement activation, has a unique spider-like shape. It is composed of six to seven identical alpha-chains with or without a single beta-chain, the chains being linked by disulfide bridges in their C-terminal parts.
Lena Kask +4 more
openaire +3 more sources
C4b-binding protein (C4BP), an important inhibitor of complement activation, has a unique spider-like shape. It is composed of six to seven identical alpha-chains with or without a single beta-chain, the chains being linked by disulfide bridges in their C-terminal parts.
Lena Kask +4 more
openaire +3 more sources
Comparison of two immunoassays for the complement protein C4b-binding protein in health and disease
International Journal of Clinical & Laboratory Research, 1995An enzyme-linked immunoassay for human C4b-binding protein (concentration range 25-400 ng/ml) was developed using two monoclonal antibodies; the intra- and interassay coefficients of variation were less than 7.2%. In 50 normal subjects, 20 patients with liver cirrhosis and 34 full-term newborns, the plasma levels of C4b-binding protein were very ...
P. M. Mannucci +4 more
openaire +3 more sources
Immunology Today, 1986
Recent cDNA sequencing data has allowed the prediction of the entire amino acid sequences of complement components factor B and C2, the complement control proteins factor H and C4b-binding protein and a partial sequence for the Cab/C4b receptor CR1. These proteins all contain internal repeating units of approximately 60 amino acids, each repeating unit
Reid, K B M +6 more
openaire +4 more sources
Recent cDNA sequencing data has allowed the prediction of the entire amino acid sequences of complement components factor B and C2, the complement control proteins factor H and C4b-binding protein and a partial sequence for the Cab/C4b receptor CR1. These proteins all contain internal repeating units of approximately 60 amino acids, each repeating unit
Reid, K B M +6 more
openaire +4 more sources
The inhibition of covalent binding of the nascent complement component C4b to its target
Russian Journal of Bioorganic Chemistry, 2000The inhibition of covalent binding of the nascent C4b fragment of the human complement component to its natural target, immunoglobulin G, was studied. To this end, an immunoenzyme system was developed. In this ELISA method, the complement was activated on the sorbed IgG molecules and the resulting nascent C4b fragment acylated IgG or interacted with a ...
Guzova Va +7 more
openaire +2 more sources
Crystal structure of complement C4b re-refined using iMDFF
, 2016T. Croll, G. Andersen
semanticscholar +1 more source